Medical specialists from Moldova, Republic of tagged as investigators in clinical trials studying Marginal Zone Lymphoma
Total 1 results
-
Vasile Musteata, MD, PhDSeen in:
- Chisinau, Institute of Oncology, ARENSIA Exploratory Medicine
Trials:- NCT05544019 (Principal Investigator)
Conditions:- Follicular Lymphoma;
- Splenic Marginal Zone Lymphoma;
- Burkitt Lymphoma;
- Plasmablastic Lymphoma;
- Waldenstrom Macroglobulinemia;
- Mantle Cell Lymphoma;
- Chronic Lymphocytic Leukemia;
- Lymphoplasmacytic Lymphoma;
- Non Hodgkin Lymphoma;
- Primary Effusion Lymphoma;
- DLBCL;
- High-grade B-cell Lymphoma;
- Primary Mediastinal Large B Cell Lymphoma;
- Nodal Marginal Zone Lymphoma;
- MALT Lymphoma;
- EBV-Positive DLBCL, Nos;
- ALK-Positive Large B-Cell Lymphoma;
- DLBCL Germinal Center B-Cell Type;
- Primary Cutaneous Follicle Center Lymphoma;
- Mature B-Cell Neoplasm;
- Pediatric-Type Follicular Lymphoma;
- IRF4 Gene Rearrangement;
- T-Cell/Histiocyte Rich Lymphoma;
- Primary Cutaneous Diffuse Large B-Cell Lymphoma;
- HHV8-Positive DLBCL, Nos;
- Duodenal-Type Follicular Lymphoma
Clinical Trials on Marginal Zone Lymphoma
-
Narendranath EpperlaWithdrawnRecurrent Marginal Zone Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Nodal Marginal Zone Lymphoma | Recurrent Nodal Marginal Zone Lymphoma | Recurrent Splenic Marginal Zone Lymphoma | Refractory Splenic Marginal Zone Lymphoma and other conditions
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingSplenic Marginal Zone Lymphoma | Marginal Zone Lymphoma | Nodal Marginal Zone LymphomaFrance, Switzerland, Italy, Belgium, Portugal
-
Narendranath EpperlaNot yet recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory Mantle Cell Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid... and other conditionsUnited States
-
International Extranodal Lymphoma Study Group (IELSG)CompletedMarginal Zone B-cell LymphomaItaly, France
-
National Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Small Lymphocytic... and other conditionsUnited States
-
BiocadCompletedSplenic Marginal Zone Lymphoma | Nodal Marginal Zone Lymphoma | Follicular Non-Hodgkin's LymphomaIndia, Russian Federation, Colombia, South Africa, Ukraine
-
International Extranodal Lymphoma Study Group (IELSG)Not yet recruitingSplenic Marginal Zone LymphomaNorway, Denmark, Sweden, Italy, Switzerland
-
University of MiamiADC Therapeutics S.A.RecruitingMarginal Zone LymphomaUnited States
-
International Extranodal Lymphoma Study Group (IELSG)RecruitingMarginal Zone LymphomaFrance, Italy, Switzerland